China SXT Pharmaceuticals Inc (SXTC) — Strategic Asset Allocation Index
China SXT Pharmaceuticals Inc (SXTC) has a Strategic Asset Allocation Index of 9.1% as of September 2022. Strategic assets (PP&E of $1.36 Million plus long-term investments of $-) total $1.36 Million, measured against net assets of $14.89 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
China SXT Pharmaceuticals Inc Strategic Asset Allocation Index (2016–2022)
This chart shows how China SXT Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of September 2022, the index stands at 9.1%, representing strategic assets of $1.36 Million against net assets of $14.89 Million USD. Explore China SXT Pharmaceuticals Inc (SXTC) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for China SXT Pharmaceuticals Inc (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China SXT Pharmaceuticals Inc from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of China SXT Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 9.7% | $1.59 Million | $1.59 Million | $- | $16.42 Million | ▼ -1.5 pp |
| 2021 | 11.2% | $1.79 Million | $1.79 Million | $- | $15.96 Million | ▼ -9.0 pp |
| 2020 | 20.2% | $1.90 Million | $1.90 Million | $- | $9.40 Million | ▲ +4.0 pp |
| 2019 | 16.3% | $1.81 Million | $1.81 Million | $- | $11.11 Million | ▼ -29.0 pp |
| 2018 | 45.3% | $1.49 Million | $1.49 Million | $- | $3.29 Million | ▲ +19.1 pp |
| 2017 | 26.2% | $485.29K | $485.29K | $- | $1.85 Million | ▼ -31.7 pp |
| 2016 | 57.9% | $430.08K | $430.08K | $- | $742.77K | — |